Pharmaceutical composition for treating atherosclerosis and application
A technology of atherosclerosis and composition, applied in the field of medicine, can solve problems such as unsatisfactory effects, achieve obvious damage to arterial endothelial cells, obvious effect, and the effect of treating arterial endothelial cell damage
Inactive Publication Date: 2017-01-04
XINXIANG MEDICAL UNIV
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
General prevention is mainly based on reasonable diet, physical exercise, and attention to rest, but the effect is not ideal
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0034] A pharmaceutical composition for treating atherosclerosis. The pharmaceutical composition is prepared from the following raw materials: 101 parts of Cyclovir buxicine D, 6 parts of glucoside and 9 parts of swertiamarin.
Embodiment 2
[0036] A pharmaceutical composition for treating atherosclerosis. The pharmaceutical composition is prepared from the following raw materials: 0.5 parts of cyclovir buxicine D, 105 parts of glucoside, and 102 parts of swertiamarin.
Embodiment 3
[0038] A pharmaceutical composition for treating atherosclerosis. The pharmaceutical composition is prepared from the following raw materials: 103 parts of cyclovir buxicine D, 7 parts of glucoside and 103 parts of swertiamarin.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention belongs to a pharmaceutical composition for treating atherosclerosis and application. The pharmaceutical composition is prepared from cyclovirobuxine D, periplocin and swertiamarin. The pharmaceutical composition has the advantages of being stable in mass control, safe, effective, natural, free of toxicity and suitable for being taken for a long term.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating atherosclerosis and its application. Background technique [0002] Atherosclerosis is a kind of arteriosclerosis, which mainly occurs in the intima of large and medium arteries, and yellow atheromatous plaques containing cholesterol and fats appear, which are mostly caused by lipid metabolism disorders and neurovascular dysfunction. Often lead to thrombosis, blood supply disorders. The onset of atherosclerosis is more common in men over 40 years old and postmenopausal women. The disease is often accompanied by hypertension, hypercholesterolemia or diabetes. Atherosclerosis is a common disease, frequently-occurring disease, one of the diseases with high mortality and disability, which seriously endangers human life and health. It is common in mental workers and is also one of the main causes of death in the elderly. . [0...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/7048A61K31/57A61P3/06A61P9/10
CPCA61K31/7048A61K31/57
Inventor 路军秀荆云马丽娟张崇赵繁荣朱茉莉牛秉轩牛慧芳潘国聘李鹏万光瑞
Owner XINXIANG MEDICAL UNIV